The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate

Wenqian Yang; Zimeng Yang; Jingru Fu; Mengran Guo; Bingjun Sun; Wei Wei; Dan Liu; Hongzhuo Liu

doi:10.1039/c8bm01175c

journal article Jan 01, 2019

The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate

Wenqian Yang Zimeng Yang Jingru Fu Mengran Guo Bingjun Sun

Wei Wei

Dan Liu

Hongzhuo Liu

Biomaterials Science Vol. 7 No. 1 pp. 419-428 · Royal Society of Chemistry (RSC)

View at Publisher Save 10.1039/c8bm01175c

Abstract

Remote loading technology is an outstanding achievement in liposome-based drug delivery systems.

Topics

No keywords indexed for this article. Browse by subject →

References

34

[1]

Deamer Biochim. Biophys. Acta (1972) 10.1016/0005-2736(72)90180-0

[2]

Mayhew Ann. N. Y. Acad. Sci. (1978) 10.1111/j.1749-6632.1978.tb22035.x

[3]

Barenholz J. Liposome Res. (2003) 10.1081/lpr-120017482

[4]

Doxil® — The first FDA-approved nano-drug: Lessons learned

Yechezkel (Chezy) Barenholz

Journal of Controlled Release 2012 10.1016/j.jconrel.2012.03.020

[5]

Batist Expert Opin. Pharmacother. (2002) 10.1517/14656566.3.12.1739

[6]

Lasic Biochim. Biophys. Acta (1995) 10.1016/0005-2736(95)00159-z

[7]

Wasserman Langmuir (2007) 10.1021/la060218k

[8]

Clerc Biochim. Biophys. Acta (1995) 10.1016/0005-2736(95)00214-6

[9]

Avnir Arthritis Rheum. (2008) 10.1002/art.23230

[10]

Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy

Daryl C. Drummond, Charles O. Noble, Zexiong Guo et al.

Cancer Research 2006 10.1158/0008-5472.can-05-4007

[11]

Li J. Pharm. Pharmacol. (2011) 10.1111/j.2042-7158.2011.01272.x

[12]

Laginha Clin. Cancer Res. (2005) 10.1158/1078-0432.ccr-05-0343

[13]

Johnston Biochim. Biophys. Acta, Biomembr. (2006) 10.1016/j.bbamem.2006.01.009

[14]

Haran Biochim. Biophys. Acta (1993) 10.1016/0005-2736(93)90105-9

[15]

Allen Cancer Res. (1992)

[16]

Bally Cancer Chemother. Pharmacol. (1990) 10.1007/bf00689270

[17]

Johnston Biochim. Biophys. Acta (2006) 10.1016/j.bbamem.2006.01.009

[18]

Li Eur. J. Pharm. Sci. (2008) 10.1016/j.ejps.2008.05.006

[19]

Li J. Liposome Res. (2012) 10.3109/08982104.2011.584880

[20]

Li Eur. J. Pharm. Sci. (2008) 10.1016/j.ejps.2008.05.006

[21]

Cui J. Controlled Release (2007) 10.1016/j.jconrel.2006.12.002

[22]

Seynhaeve Cancer Res. (2007) 10.1158/0008-5472.can-07-1599

[23]

Ramesh Biomed. Chromatogr. (2010) 10.1002/bmc.1345

[24]

Fassberg J. Pharm. Sci. (1992) 10.1002/jps.2600810718

[25]

The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy

Frank C. Passero, Dimitra Grapsa, Kostas N. Syrigos et al.

Expert Review of Anticancer Therapy 2016 10.1080/14737140.2016.1192471

[26]

Yang Asian J. Pharm. Sci. (2018) 10.1016/j.ajps.2018.08.003

[27]

D. B. Fenske and P. R.Cullis , in Liposomes, Pt E , ed. N. Duzgunes , Elsevier Academic Press Inc. , San Diego , 2005 , vol. 391 , pp. 7–40

[28]

Fenske Biochim. Biophys. Acta (1998) 10.1016/s0005-2736(98)00166-7

[29]

Li Biochim. Biophys. Acta (1998) 10.1016/s0005-2736(98)00175-8

[30]

Cui J. Controlled Release (2007) 10.1016/j.jconrel.2006.12.002

[31]

Cui J. Controlled Release (2007) 10.1016/j.jconrel.2006.12.002

[32]

Harrigan Biochim. Biophys. Acta (1993) 10.1016/0005-2736(93)90218-o

[33]

Drummond Pharmacol. Rev. (1999) 10.1016/s0031-6997(24)01426-1

[34]

Gabizon Clin. Pharmacokinet. (2003) 10.2165/00003088-200342050-00002

Metrics

34

Citations

34

References

Details

Published: Jan 01, 2019
Vol/Issue: 7(1)
Pages: 419-428
License: View

Authors

W

Wenqian Yang